S. 5502, Critical Infrastructure Designation. Quorum's AI analysis reads it as a net benefit — and names who gains.
S. 5502 · Net good
What it does
This bill designates biotechnology and biomanufacturing infrastructure as critical infrastructure under federal cybersecurity protection, assigning CISA (the Cybersecurity and Infrastructure Security Agency) to oversee its security. It requires CISA to identify stakeholders, coordinate with industry groups and information-sharing organizations, and submit work plans and progress reports to Congress on protecting this sector.
The analysis names biotechnology companies — and 3 more groups — among the beneficiaries.
The trade-off
CISA gains new staffing and resource demands to manage a sector with no pre-existing Sector-Specific Agency, potentially straining agency capacity.
Transparency scores 75%, with a medium warning level and no provisions unrelated to the bill's subject.
Who is behind it
Filed by Maggie Hassan. Cosponsored by Todd Young.
The week in bills
One email, Sunday: what Congress passed, what it changed, and who paid.
One link arrives to confirm the address. It is used for this email and nothing else, and every issue carries an unsubscribe link.